(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -4.24% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.49%.
Pfizer's revenue in 2026 is $63,696,000,000.On average, 30 Wall Street analysts forecast PFE's revenue for 2026 to be $355,722,328,363,079, with the lowest PFE revenue forecast at $332,399,264,036,891, and the highest PFE revenue forecast at $377,774,365,478,920. On average, 30 Wall Street analysts forecast PFE's revenue for 2027 to be $342,225,501,304,327, with the lowest PFE revenue forecast at $313,533,344,457,301, and the highest PFE revenue forecast at $378,777,508,030,584.
In 2028, PFE is forecast to generate $316,246,389,085,665 in revenue, with the lowest revenue forecast at $289,304,032,030,462 and the highest revenue forecast at $352,085,936,613,297.